Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study

Background: The musculoskeletal toxicity of immune checkpoint inhibitors (ICIs) is receiving increasing attention with clinical experience. Nevertheless, the absence of a systematic investigation into the musculoskeletal toxicity profile of ICIs currently results in the under-recognition of associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hao, Li, Yumin, Li, Jie, Zhang, Qiongchi, Wu, Jingtao, Li, Xinyu, Meng, Liesu, Cao, Shuai, Li, Haopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595016/
https://www.ncbi.nlm.nih.gov/pubmed/37881181
http://dx.doi.org/10.3389/fphar.2023.1199031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595016/
https://www.ncbi.nlm.nih.gov/pubmed/37881181
http://dx.doi.org/10.3389/fphar.2023.1199031

Ejemplares similares